Globalization of clinical trials: How should we interpret differences in outcomes?

Journal of the American College of Cardiology

Volumn 58, Issue 9, 2011, Pages 923-924

  Massie, Barry M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

beta blocker; clinical trials; geography; heart failure; mortality

Indexed keywords

BISOPROLOL; BUCINDOLOL; CAPTOPRIL; CARVEDILOL; METOPROLOL; PLACEBO;

CLINICAL TRIAL (TOPIC); EDITORIAL; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION; SURVIVAL RATE; SYSTOLIC HEART FAILURE; TREADMILL EXERCISE; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEART FAILURE; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WORLD HEALTH;

EID: 84860391921     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.04.027     Document Type: Editorial

References (13)

1. Captopril Multicenter Study Group A placebo-controlled trial of captopril in refractory chronic congestive heart failure J Am Coll Cardiol 2 1983 755 763
2. T.J. Newman, C.S. Maskin, L.G. Dennick, J.H. Meyer, B.G. Hallows, and W.H. Cooper Effects of captopril on survival in patients with heart failure Am J Med 84 Suppl 1988 140 144
3. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure Results of the Cooperative North Scandinavian Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
4. B.M. Massie, J.G. Cleland, and P.W. Armstrong Regional differences in the characteristics and treatment of patients participating in an international heart failure trial The Assessment of Treatment with Lisinopril and Survival (ATLAS) J Card Fail 4 1998 3 8 (Pubitemid 28252535)
5. S.W. Glickman, J.G. McHutchison, and E.D. Peterson Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 2009 816 823
6. W.G. Stough, F. Zannad, B. Pitt, and S. Goldstein Globalization of cardiovascular clinical research: the balance between meeting medical needs and maintaining scientific standards Am Heart J 154 2007 232 238 (Pubitemid 47069136)
7. C.M. O'Connor, M. Fiuzat, and K. Swedberg Influence of global region on outcomes in heart failure beta-blocker trials J Am Coll Cardiol 58 2011 915 922
8. MERIT-HF Investigators Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
9. M. Packer, A.J. Coats, and M.B. Fowler Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658 (Pubitemid 32479962)
10. The Beta Blocker Evaluation of Survival Trial Investigators A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N Engl J Med 344 2001 1659 1667
11. N. Aiyar, P. Andreka, and L.C. Olson Bucindolol displays intrinsic sympathomimetic activity in human myocardium Circulation 106 2002 2429 2434 (Pubitemid 34556397)
12. CIBIS II Investigators The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
13. J. Moore, D. Mason, and S. Green Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165 G>C Hum Mutat 14 1999 271